Larvol Delta - BioPath-Holdings-Reports-Solid-Tumor-Patient-Response-Supporting-BP1001As-Compelling-Potential-as-Treatment-for-Advanced-Solid-Tumors

prexigebersen-A (BP1001-A) - Bio-Path

https://www.globenewswire.com/news-release/2024/08/21/2933394/0/en/Bio-Path-Holdings-Reports-Solid-Tumor-Patient-Response-Supporting-BP1001-A-s-Compelling-Potential-as-Treatment-for-Advanced-Solid-Tumors.html

Aug 21, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next